Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rachel E. Wittenberg has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic Causes of Thoracic Aortic Aneurysm: A Review

    by Rachel E. Wittenberg, Mark E. Lindsay

    Thoracic aortic aneurysm (TAA) is an important cause of cardiovascular morbidity and mortality. TAA may occur due to inheritable genetic variants affecting the TGFβ signaling cascade, the extracellular matrix, or smooth muscle contraction, which are essential to maintain connective tissue homeostasis and vascular wall integrity. In this review, we summarize the available evidence on the genetics of thoracic aortic aneurysm including known syndromic and non-syndromic hereditary thoracic aortic disorders, the increasingly recognized role of polygenic risk, and the association of TAA with other arteriopathies. We also discuss the evolving role of genetic testing for patients with TAA. A better understanding of genetic predictors for TAA has the potential to improve screening, risk stratification, and the medical and surgical management for this patient population.

  • Adapting Cardiovascular Disease Data to Inform Policy Goals

    by Rachel E. Wittenberg, Oyere K. Onuma

  • Open Access

    Coronary Artery Anomalies in Review: Anomalous Origin, Aneurysms, and Fistulae

    by Jack A. Hoover, Keshika Catakam, Rachel E. Wittenberg, Jordan P. Bloom, Doreen DeFaria Yeh, Q. Joyce Han, Ada C. Stefanescu Schmidt

    Coronary artery anomalies are rare congenital abnormalities involving abnormal coronary artery origin and incomplete/abnormal vessel development. These anomalies encompass a broad anatomical spectrum with varied clinical presentations ranging from sudden cardiac arrest in young athletes to incidental findings in asymptomatic adults. While more data on anatomy and clinical presentation has emerged in the last decade, management remains highly individualized, guided by clinical presentation, anatomical characteristics, and patient preferences. This review provides an overview of each anomaly and recent advances in imaging, surgical planning, and risk stratification. We also highlight the challenges in optimizing management strategies, addressing gaps in evidence, and achieving consensus to refine risk stratification tools and support clinical decision-making.


  • Open Access

    Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG

    by Julia L. Marshall, Iman Satti, Mirvat Surakhy, Stephanie A. Harris, Hazel Morrison, Rachel E. Wittenberg, Marco Polo Peralta Alvarez, Shuailin Li, Raquel Lopez Ramon, Emily Hoogkamer, et al.

    The development of an effective vaccine against Mycobacterium tuberculosis is hampered by an incomplete understanding of immunoprotective mechanisms. We utilise an aerosol human challenge model using attenuated Mycobacterium bovis BCG, in BCG-naïve UK adults. The primary endpoint of this study (NCT03912207) was to characterise the early immune responses induced by aerosol BCG infection, the secondary endpoint was to identify immune markers associated with in-vitro protection. Blinded volunteers were randomised to inhale 1 × 107 CFU aerosolised BCG or 0.9% saline (20:6); and sequentially allocated to bronchoscopy at day 2 or 7 post-inhalation (10 BCG, 3 saline each timepoint). In the bronchoalveolar lavage post-aerosol BCG infection, there was an increase in frequency of eosinophils, neutrophils, NK cells and Donor-Unrestricted T cells at day 7, and the frequency of antigen presenting cells decreased at day 7 compared with day 2. The frequency of interferon-gamma+ BCG-specific CD4+ T cells increased in the BAL and peaked in the blood at day 7 post-BCG infection compared to day 2. BAL cells at day 2 and day 7 upregulated gene pathways related to phagocytosis, MHC-II antigen loading, T cell activation and proliferation. BCG’s lack of key virulence factors and its failure to induce granulomas, may mean the observed immune responses do not fully recapitulate Mycobacterium tuberculosis infection. However, human infection models can provide unique insights into early immune mechanisms, informing vaccine design for complex pathogens.


  • Functional Status Trajectory and Survival for Adult Patients Undergoing Heart Transplantation

    by Rachel E. Wittenberg, Elizabeth Mostofsky, Murray A. Mittleman

    Background: Transplantation is a critical treatment for end‐stage heart disease and improves length and quality of life. We investigated predictors of functional status improvement following transplant and the association between functional status trajectory and survival.Methods: We conducted a retrospective cohort study using Scientific Registry of Transplant Recipients data on 34 009 US adults who underwent heart transplant 2006–2021. Functional status was measured using the Karnofsky Performance Scale (KPS; 0%–100%). Linear regression with stepwise selection was used to identify predictors of KPS trajectories. Kaplan–Meier curves and adjusted Cox proportional hazard models were used to compare survival.Results: Mean KPS was low at listing (47.9%) and transplant (45.6%) and increased to 85.7% and 89.2% at 1‐ and 5‐years posttransplant. Independent predictors of KPS trajectory in the first year included hypertension, diabetes, BMI, prior tobacco, previous malignancy, age, sex, education level, insurance type, etiology of heart disease, prior cardiac surgery, “1A” waitlist priority, and hospitalization status. KPS trajectory during the waitlist period and the first year posttransplant predicted survival, independent of baseline KPS. Decrease in KPS > −30% and −30% to < 0% in the first year were associated with 5.74 (3.45–9.56) and 2.09 (1.69–2.59) times higher mortality than stable KPS after adjusting for baseline KPS and other factors. Poor KPS trajectory in the waitlist period was similarly associated with higher mortality.Conclusions: Functional status improvement is an important outcome following heart transplantation, and KPS trajectory predicts survival. Most patients achieve high KPS, but clinical and social interventions may optimize KPS trajectory for high‐risk patients.


  • Open Access

    Associations With Adverse Postoperative Outcomes in Children Undergoing Atrial Septal Defect Closure in Lower-Resource Settings

    by Rachel E. Wittenberg, Kimberlee Gauvreau, María Belén Desocio, Xinwei Du, Jessin P. Jayasankar, Néstor Sandoval, Kathy J. Jenkins


  • Open Access

    Preoperative Malnutrition Increases Risk of In‐Hospital Mortality, Major Infection, and Longer Intensive Care Unit Stay After Ventricular Septal Defect Closure

    by Rachel E. Wittenberg, Kimberlee Gauvreau, Christopher P. Duggan, Xinwei Du, Do Giang, Kishore Jayanthi, Nestor Sandoval, Sivakumar Sivalingam, Xiaolei Zhao, Kathy J. Jenkins

    Background: High energy requirements and poor feeding can lead to growth failure in patients with ventricular septal defect (VSD), but effects of preoperative malnutrition on surgical outcomes are poorly understood, especially in low‐resource settings. Methods and Results: We analyzed a cohort of children Z score, <−3), moderate wasting (−3Z score≤−2), underweight (weight‐for‐age Z score, ≤−2), and stunting (height‐for‐age Z score, ≤−2) according to World Health Organization Child Growth Standards. Among 10 966 children undergoing VSD closure in the analyzed cohort, 8136 (74%) were membranous VSDs. Median age was 9.6 months (interquartile range, 3.6–12.0), and 4088 (37.3%) had wasting/severe wasting, 5029 (45.9%) had underweight, and 3515 (32.1%) had stunting. There were 4749 (43.3%) children who met the criteria for ≥2 malnutrition categories. Overall, 84 patients (0.8%) died in‐hospital, and 199 (1.8%) had major infection. Severe wasting (OR, 3.38 [95% CI, 1.55–7.35]; P =0.002), underweight (OR, 6.46 [95% CI, 2.81–14.8]; P P =0.003) were independent predictors of mortality. Similar results were observed for infection and duration of intensive care unit stay. Underweight was the strongest predictor of adverse outcomes. Children meeting criteria for all 3 (stunting, wasting, and underweight) had 17.2 times higher odds of mortality ( P <0.001) than nonmalnourished children. Conclusions: Malnutrition was associated with mortality, infection, and longer intensive care unit stay in a global cohort of children undergoing VSD closure.


  • Open Access

    Robot-Assisted Laparoscopic Reduction of Gastroesophageal Intussusception With Gastropexy

    by Rachel E. Wittenberg, Benjamin B. Scott, Dominic P. Recco, Christopher S. Digesu, Michael S. Kent

  • Open Access

    Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants

    by Iman Satti, Rachel E. Wittenberg, Shuailin Li, Stephanie A. Harris, Rachel Tanner, Deniz Cizmeci, Ashley Jacobs, Nicola Williams, Humphrey Mulenga, Helen A. Fletcher, et al.

    Tuberculosis vaccine development is hindered by the lack of validated immune correlates of protection. Exploring immune correlates of risk of disease and/or infection in prospective samples can inform this field. We investigate whether previously identified immune correlates of risk of TB disease also associate with increased risk of M.tb infection in BCG-vaccinated South African infants, who became infected with M.tb during 2-3 years of follow-up. M.tb infection is defined by conversion to positive reactivity in the QuantiFERON test. We demonstrate that inflammation and immune activation are associated with risk of M.tb infection. Ag85A-specific IgG is elevated in infants that were subsequently infected with M.tb, and this is coupled with upregulated gene expression of immunoglobulin-associated genes and type-I interferon. Plasma levels of IFN- $$\alpha$$ α 2, TNF- $$\alpha$$ α , CXCL10 (IP-10) and complement C2 are also higher in infants that were subsequently infected with M.tb.


  • Open Access

    Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants

    by Iman Satti, Rachel Wittenberg, Shuailin Li, Stephanie Harris, Rachel Tanner, Deniz Cizmeci, Ashley Jacobs, Nicola Williams, Humphrey Mulenga, Helen Fletcher, et al.

    Tuberculosis vaccine development is hindered by the lack of validated immune correlates of protection. Exploring immune correlates of risk of disease and/or infection in prospective samples can inform this field. We investigated whether previously identified immune correlates of risk of TB disease also associate with increased risk of M.tb infection in BCG-vaccinated South African infants, who became infected with M.tb during 2–3 years of follow-up. M.tb infection was defined by conversion to positive reactivity in the QuantiFERON test. We demonstrate that inflammation and immune activation are associated with risk of M.tb infection. Ag85A-specific IgG was elevated in infants that were subsequently infected with M.tb, and this was coupled with upregulated gene expression of immunoglobulin-associated genes and type-I interferon. Plasma levels of IFN-\(\alpha\)2, TNF-\(\alpha\), CXCL10 (IP-10) and complement C2 were also higher in infants that were subsequently infected with M.tb.